NCT03688204View on ClinicalTrials.gov

Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions
Breast Cancer Risk
Trial Locations (3)

25701

Edwards Comprehensive Cancer Center, Huntington

91505

Providence Roy and Patricia Disney Family Cancer Center, Burbank

92868

St Joseph Hospital of Orange, Orange

Sponsors

Lead Sponsor

Ambry Genetics
All Listed Sponsors
lead

Ambry Genetics

INDUSTRY

NCT03688204 - Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer | Biotech Hunter | Biotech Hunter